Cited by 11Neuroscience and Neuropharmacology ResearchNicotinic Acetylcholine Receptors StudyReceptor Mechanisms and Signaling

Milestone Review: Unlocking the Proteomics of Glycine Receptor Complexes

Open access
Fraser, Sean D., Klaassen, Remco V., Villmann, Carmen, Smit, August B., Harvey, Robert J.·2025·Journal of Neurochemistry

Abstract

Glycine receptors (GlyRs) are typically known for mediating inhibitory synaptic transmission within the spinal cord and brainstem, but they also have key roles in embryonic brain development, learning/memory, inflammatory pain sensitization, and rhythmic breathing. GlyR dysfunction has been implicated in multiple neurological disease states, including startle disease (GlyR α1β) and neurodevelopmental disorders (NDDs) including autism spectrum disorder (ASD), intellectual disability (ID), developmental delay (DD) and epilepsy (GlyR α2). However, GlyRs do not operate in isolation but depend upon stable and transient protein–protein interactions (PPIs) that influence synaptic localization, homeostasis, signaling pathways, and receptor function. Despite the affinity purification of GlyRs using the antagonist strychnine over four decades ago, we still have much to learn about native GlyR stoichiometry and accessory proteins. In contrast to other neurotransmitter receptors, < 20 potential GlyR interactors have been identified to date. These include some well‐known proteins that are vital to inhibitory synapse function, such as the postsynaptic scaffolding protein gephyrin and the RhoGEF collybistin. However, the majority of known interactors either bind to the GlyR α1 and β subunits, or the binding partner in the GlyR complex is unknown. Several potential GlyR interactors are not found at inhibitory synapses and/or have no clear functional role. Moreover, other GlyR interactors are secondary interactors that bind indirectly, for example, via gephyrin. In this review, we provide a critical evaluation of known GlyR interacting proteins and methodological limitations to date. We also provide a road map for the use of innovative and emerging interaction proteomic techniques that will unlock the GlyR interactome. With the emergence of disease‐associated missense mutations in the α1, α2 and β subunit intracellular domains in startle disease and NDDs, understanding the identity and roles of GlyR accessory proteins is vital in understanding GlyR function and dysfunction in health and disease. image

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.70061

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Understanding the identity and roles of GlyR accessory proteins is vital for deciphering GlyR function and dysfunction in health and disease, particularly given the emergence of disease-associated missense mutations in the α1, α2, and β subunit intracellular domains linked to startle disease and neurodevelopmental disorders.

    “Understanding the identity and roles of GlyR accessory proteins is vital for deciphering GlyR function and dysfunction in health and disease, particularly given the emergence of disease-associated missense mutations in the α1, α2, and β subunit intracellular domains linked to startle disease (associated with GlyR α1 and β subunits) and neurodevelopmental disorders such as autism, intellectual dis”

    From Molecular Physiology of the Neuronal Synapse (2026) · cites this paper as [62]

    Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable, 1 not checked. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • The interplay between functional and structural changes ensures that synaptic strength is not only modulated but also physically maintained over time.

    “This interplay between functional and structural changes ensures that synaptic strength is not only modulated but also physically maintained over time [62].”

    From Molecular Physiology of the Neuronal Synapse (2026) · cites this paper as [62]

    The sections on gephyrin and other GlyR β interactors describe how synaptic signaling changes receptor–scaffold binding and how accessory proteins affect receptor clustering and mobility. The review thus supports a connection between functional regulation and synaptic structure, but it does not establish that this interplay ensures synaptic strength is physically maintained over time. Page numbers were not available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The full complement of proteins interacting with native GlyRs remains largely unknown, with fewer than 20 potential interactors identified to date compared to other neurotransmitter receptors.

    “Despite these advancements, the full complement of proteins interacting with native GlyRs remains largely unknown, with fewer than 20 potential interactors identified to date compared to other neurotransmitter receptors [62].”

    From Molecular Physiology of the Neuronal Synapse (2026) · cites this paper as [62]

  • Many known GlyR interactors either bind specifically to the GlyR α1 and β subunits, or their precise binding partner within the GlyR complex is unclear.

    “Many known interactors either bind specifically to the GlyR α1 and β subunits, or their precise binding partner within the GlyR complex is unclear.”

    From Molecular Physiology of the Neuronal Synapse (2026) · cites this paper as [62]

  • Some identified GlyR interactors are not found at inhibitory synapses or lack a clear functional role, while others are secondary interactors that bind indirectly, for example, via gephyrin.

    “Furthermore, some identified GlyR interactors are not found at inhibitory synapses or lack a clear functional role, while others are secondary interactors that bind indirectly, for example, via gephyrin [62].”

    From Molecular Physiology of the Neuronal Synapse (2026) · cites this paper as [62]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 169 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Fraser, S. D., Klaassen, R. V., Villmann, C., Smit, A. B., & Harvey, R. J.
Affiliations
  • University of the Sunshine Coast (AU)
  • Amsterdam Neuroscience (NL)
  • University of Würzburg (DE)
Corresponding author
Harvey, Robert J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2025-04
Volume
169
Issue
4
Pages
e70061-e70061
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W4409844824
Cited by
10
References
169
Citations by year
2026: 10
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, cc-by)
Funders
  • Australian Research Council (Discovery project DP250101477)
  • Deutsche Forschungsgemeinschaft (VI586)
  • University of the Sunshine Coast (980029932)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
glycine receptor, protein-protein interaction, accessory proteins, gephyrin, collybistin, startle disease, neurodevelopmental disorders, autism spectrum disorder, intellectual disability, epilepsy, missense mutations, inhibitory synapses
MeSH terms
Animals, Humans, Receptors, Glycine, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review